Unicycive Announces Renazorb Pre-clinical and Clinical Data

/PRNewswire/ -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease,...

Related Keywords

Boston , Massachusetts , United States , Shalabh Gupta , National Kidney Foundation , Prnewswire Unicycive Therapeutics Inc , Drug Administration , Nasdaq , Spring Clinical Meeting , Chief Executive , Clinical Meeting , Dioxycarbonate Effectively Reduces Phosphate , Unicycive Therapeutics Inc ,